← back to search

Harvey A. Risch

Dana-Farber Cancer Institute · US
Area of research
Reproductive Medicine · Oncology
Research interest
Research interests include Ovarian cancer diagnosis and treatment, Pancreatic and Hepatic Oncology Research, Genetic Associations and Epidemiology, and Liver Disease Diagnosis and Treatment.
h-index
99
citations
41,934
works
921
NIH funding
primary concept
email

Recent publications

GWAS meta-analysis identifies five susceptibility loci for endometrial cancer
EBioMedicine 2025cited by 2position: middledoi
Different diabetes types and pancreatic ductal adenocarcinoma: a Mendelian randomization and pathway/gene-set analysis
JNCI Journal of the National Cancer Institute 2025cited by 1position: middledoi
Understanding risk factors for endometrial cancer in young women
JNCI Journal of the National Cancer Institute 2024cited by 24position: middledoi
Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2)
Cancer Epidemiology Biomarkers & Prevention 2024cited by 17position: middledoi
Genome-Wide Analysis to Assess if Heavy Alcohol Consumption Modifies the Association between SNPs and Pancreatic Cancer Risk
Cancer Epidemiology Biomarkers & Prevention 2024cited by 1position: middledoi
Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions
JNCI Journal of the National Cancer Institute 2023cited by 30position: middledoi
Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis
JNCI Journal of the National Cancer Institute 2023cited by 25position: middledoi
Risk prediction models for endometrial cancer: development and validation in an international consortium
JNCI Journal of the National Cancer Institute 2023cited by 22position: middledoi
Night shift work, sleep duration and endometrial cancer risk: A pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2)
Sleep Medicine Reviews 2023cited by 12position: middledoi
Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
Cancer Epidemiology Biomarkers & Prevention 2023cited by 6position: middledoi
Effects of risk factors for ovarian cancer in women with and without endometriosis
Fertility and Sterility 2022cited by 18position: middledoi
eQTL Set–Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal Adenocarcinoma
Cancer Epidemiology Biomarkers & Prevention 2022cited by 8position: middledoi
Reproductive Factors Do Not Influence Survival with Ovarian Cancer
2022cited by 2position: middle
Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies
American Journal of Clinical Nutrition 2021cited by 39position: middledoi
A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer
Genome Medicine 2021cited by 33position: middledoi
Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer
Human Genetics and Genomics Advances 2021cited by 17position: middledoi
Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association
Gynecologic Oncology 2021cited by 12position: middledoi
Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer.
Apollo (University of Cambridge) 2021cited by 0position: middledoi
Association Between Breastfeeding and Ovarian Cancer Risk
JAMA Oncology 2020cited by 272position: middledoi
Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection
The American Journal of Medicine 2020cited by 174position: lastdoi
Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers
Nature Communications 2020cited by 131position: middledoi
Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)
Reviews in Cardiovascular Medicine 2020cited by 87position: middledoi
Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer
International Journal of Cancer 2020cited by 73position: middledoi
Estimation of the carrier frequency of fumarate hydratase alterations and implications for kidney cancer risk in hereditary leiomyomatosis and renal cancer
Cancer 2020cited by 42position: middledoi
Expanding Our Understanding of Ovarian Cancer Risk: The Role of Incomplete Pregnancies
JNCI Journal of the National Cancer Institute 2020cited by 37position: middledoi
Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk
Cancer Epidemiology Biomarkers & Prevention 2020cited by 32position: middledoi
Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival
Gynecologic Oncology 2020cited by 28position: middledoi
Pregnancy outcomes and risk of endometrial cancer: A pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium
International Journal of Cancer 2020cited by 26position: middledoi
Sex-Specific Genetic Associations for Barrett’s Esophagus and Esophageal Adenocarcinoma
Gastroenterology 2020cited by 26position: middledoi
Mendelian Randomization Analysis of n-6 Polyunsaturated Fatty Acid Levels and Pancreatic Cancer Risk
Cancer Epidemiology Biomarkers & Prevention 2020cited by 14position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Anna H. Wu · University of Southern California10 papers (2012–2022)Thomas L. Vaughan · Columbia University7 papers (2012–2019)David C. Whiteman · University of Edinburgh7 papers (2012–2019)Leslie Bernstein · Beckman Research Institute7 papers (2012–2019)Marilie D. Gammon · University of North Carolina at Chapel Hill6 papers (2012–2019)Douglas A. Corley · Kaiser Permanente San Francisco Medical Center6 papers (2012–2019)Wong‐Ho Chow · Chi Mei Medical Center5 papers (2012–2019)Weimin Ye · Fujian Medical University5 papers (2012–2015)Alan G. Casson · University of Saskatchewan5 papers (2012–2015)Farin Kamangar · Morgan State University4 papers (2012–2015)Penelope M. Webb · QIMR Berghofer Medical Research Institute4 papers (2012–2022)Steven Gallinger · Ontario Institute for Cancer Research4 papers (2012–2019)Gloria M. Petersen · Mayo Clinic in Florida4 papers (2012–2019)Paige M. Bracci · University of California System4 papers (2012–2019)Olof Nyrén · Karolinska Institutet4 papers (2012–2015)Liam Murray · University of Massachusetts Chan Medical School4 papers (2012–2015)Neal D. Freedman · Division of Program Coordination Planning and Strategic Initiatives4 papers (2012–2015)Laura J. Hardie · University of Leeds3 papers (2014–2019)Marc T. Goodman · Cancer Institute of New South Wales3 papers (2020–2022)Andrew Berchuck · Duke University3 papers (2020–2022)